Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nicholas J. Vogelzang
US Oncology Research/Comprehensive Cancer Centers of Nevada
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
177 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitatsklinikum Fur Urologie Und Andrologie
Salzburg, Austria
- Akh Universitatskrankenhaus Wien
Vienna, Austria
- Krankenhaus Barmherzige Brueder
Vienna, Austria
- N.N. Alexandrov National Research Center
Lesnoy, Belarus
- Minsk City Oncological Hospital
Minsk, Belarus
- Clinique D'Oncologie Medicale Institut Jules Bordet
Brussels, Belgium
- Cliniques Universitaires Saint Luc- Urologie
Brussels, Belgium
- Erasme Hospital- Urologie
Brussels, Belgium
- Urologie Uz Gent
Ghent, Belgium
- Urology Department St. Elizabeth Ziekenhuis
Turnhout, Belgium
- Specialized Hospital for Active Treatment in Oncology
Haskovo, Bulgaria
- Central Oncology Hospital
Plovdiv, Bulgaria
- Complex Oncology Center
Plovdiv, Bulgaria
- Multifunctional Hospital for Active Treatment Serdika
Sofia, Bulgaria
- Specialized Hospital for Active Treatment of Oncology Diseases
Sofia, Bulgaria
- General Hospital Varazdin
Varaždin, Croatia
- Clinical Hospital Center Zagreb
Zagreb, Croatia
- University Hospital Center Sisters of Charity
Zagreb, Croatia
- Onkologicke Centrum, Nemocnice Chomutov
Chomutov, Czechia
- Klinika Onkologie A Radioterapie, Fakultni Nemocnice
Hradec Králové, Czechia
- Nemocnice Jihlava, Urologicke Oddeleni
Jihlava, Czechia
- Urologicke Oddeleni, Krajska Nemocnice
Liberec, Czechia
- Onkologicka Klinika, Fakultni Nemocnice
Olomouc, Czechia
- Klinika Onkologicka, Fakultni Nemocnice
Ostrava-Poruba, Czechia
- Fakultni Nemocnice Kralovske Vinohrady
Prague, Czechia
- Fakultni Nemocnice V Motole
Prague, Czechia
- Thomayerova Nemocnice
Prague, Czechia
- Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
- Krajska Zdravotni, Urologicke Oddeleni
Ústí nad Labem, Czechia
- Rigshospitalet
Copenhagen, Denmark
- Hegp Medical Oncology
Paris, France
- Hopital St. Joseph
Paris, France
- Hospital Cochin, Service de Urologie
Paris, France
- St-Louis Idf Medical Oncology
Paris, France
- Hia Begin
Saint-Mandé, France
- Hospital Civil de Strasbourg
Strasbourg, France
- Charite Universitatsklinikum Berlin
Berlin, Germany
- Stadtisches Klinikum Braunschweig
Braunschweig, Germany
- Klinik Und Poliklinik Urologie
Cologne, Germany
- Universtatsklinikum Carl Gustav Carus
Dresden, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 May 2014
- Primary completion
- 28 Jan 2020
- Completion
- 28 Jan 2020
- Last update posted
- 6 Apr 2021
- Registered enrollment
- 1,182
- Registry id
- NCT02111577
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.